Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: A multicenter, prospective, randomized controlled trial.

Published on May 1, 2021in Phytomedicine4.268
· DOI :10.1016/J.PHYMED.2020.153242
Qingquan Liu8
Estimated H-index: 8
Sources
Abstract
Abstract Background Coronavirus disease 2019 (Covid-19) has resulted in a global outbreak. Few existing targeted medications are available. Lianhuaqingwen (LH) capsule, a repurposed marketed Chinese herb product, has been proven effective for influenza. Purpose To determine the safety and efficacy of LH capsule in patients with Covid-19. Methods We did a prospective multicenter open-label randomized controlled trial on LH capsule in confirmed cases with Covid-19. Patients were randomized to receive usual treatment alone or in combination with LH capsules (4 capsules, thrice daily) for 14 days. The primary endpoint was the rate of symptom (fever, fatigue, coughing) recovery. Results We included 284 patients (142 each in treatment and control group) in the full-analysis set. The recovery rate was significantly higher in treatment group as compared with control group (91.5% vs. 82.4%, P=0.022). The median time to symptom recovery was markedly shorter in treatment group (median: 7 vs. 10 days, P 0.05). No serious adverse events were reported. Conclusion In light of the safety and effectiveness profiles, LH capsules could be considered to ameliorate clinical symptoms of Covid-19.
📖 Papers frequently viewed together
77 Citations
374 Citations
202060.39The Lancet
13.3k Citations
References15
Newest
#1Xin Zou (SJTU: Shanghai Jiao Tong University)H-Index: 4
#2Ke Chen (SJTU: Shanghai Jiao Tong University)H-Index: 57
Last. Ze-Guang Han (SJTU: Shanghai Jiao Tong University)H-Index: 49
view all 6 authors...
It has been known that, the novel Coronavirus, 2019-nCoV, which is considered similar to SARS-CoV and originated from Wuhan (China), invades human cells via the receptor angiotensin converting enzyme II (ACE2). Moreover, lung cells that have ACE2 expression may be the main target cells during 2019-nCoV infection. However, some patients also exhibit non-respiratory symptoms, such as kidney failure, implying that 2019-nCoV could also invade other organs. To construct a risk map of different human ...
1,078 CitationsSource
#1Zhe XuH-Index: 14
#2Lei ShiH-Index: 8
Last. Fu-Sheng WangH-Index: 66
view all 18 authors...
4,472 CitationsSource
#1Li Runfeng (Guangzhou Medical University)H-Index: 1
#2Hou Yunlong (Hebei University)H-Index: 1
Last. Yang Zi-feng (Guangzhou Medical University)H-Index: 1
view all 18 authors...
Abstract Purpose Lianhuaqingwen (LH) as traditional Chinese medicine (TCM) formula has been used to treat influenza and exerted broad-spectrum antiviral effects on a series of influenza viruses and immune regulatory effects [ 1 ]. The goal of this study is to demonstrate the antiviral activity of LH against the novel SARS-CoV-2 virus and its potential effect in regulating host immune response. Methods The antiviral activity of LH against SARS-CoV-2 was assessed in Vero E6 cells using CPE and pla...
259 CitationsSource
Therapeutic options in response to the 2019-nCoV outbreak are urgently needed. Here, we discuss the potential for repurposing existing antiviral agents to treat 2019-nCoV, some of which are already moving into clinical trials. Therapeutic options in response to the 2019-nCoV outbreak are urgently needed. Here, we discuss the potential for repurposing existing antiviral agents to treat 2019-nCoV, some of which are already moving into clinical trials.
949 CitationsSource
Background: The coronavirus disease 2019 (COVID-19) outbreak originating in Wuhan, Hubei province, China, coincided with chunyun, the period of mass migration for the annual Spring Festival. To contain its spread, China adopted unprecedented nationwide interventions on January 23 2020. These policies included large-scale quarantine, strict controls on travel and extensive monitoring of suspected cases. However, it is unknown whether these policies have had an impact on the epidemic. We sought to...
659 CitationsSource
#1Joseph T. Wu (Li Ka Shing Faculty of Medicine, University of Hong Kong)H-Index: 49
#2Kathy Leung (Li Ka Shing Faculty of Medicine, University of Hong Kong)H-Index: 17
Last. Gabriel M. Leung (Li Ka Shing Faculty of Medicine, University of Hong Kong)H-Index: 96
view all 3 authors...
Summary Background Since Dec 31, 2019, the Chinese city of Wuhan has reported an outbreak of atypical pneumonia caused by the 2019 novel coronavirus (2019-nCoV). Cases have been exported to other Chinese cities, as well as internationally, threatening to trigger a global outbreak. Here, we provide an estimate of the size of the epidemic in Wuhan on the basis of the number of cases exported from Wuhan to cities outside mainland China and forecast the extent of the domestic and global public healt...
2,677 CitationsSource
Abstract Background Since December 2019, when coronavirus disease 2019 (Covid-19) emerged in Wuhan city and rapidly spread throughout China, data have been needed on the clinical characteristics of...
14.1k CitationsSource
#1Xiaoqiang Chai (Fudan University)H-Index: 2
#2Hu LH-Index: 1
Last. Jia-Bin Cai (Fudan University)H-Index: 16
view all 12 authors...
A newly identified coronavirus, 2019-nCoV, has been posing significant threats to public health since December 2019. ACE2, the host cell receptor for severe acute respiratory syndrome coronavirus (SARS), has recently been demonstrated in mediating 2019-nCoV infection. Interestingly, besides the respiratory system, substantial proportion of SARS and 2019-nCoV patients showed signs of various degrees of liver damage, the mechanism and implication of which have not yet been determined. Here, we per...
422 CitationsSource
#1Manli Wang (CAS: Chinese Academy of Sciences)H-Index: 18
#2Ruiyuan CaoH-Index: 4
Last. Gengfu Xiao (CAS: Chinese Academy of Sciences)H-Index: 32
view all 10 authors...
3,735 CitationsSource
#1Qiang Huang (Fudan University)H-Index: 16
#2Andreas Herrmann (Humboldt University of Berlin)H-Index: 72
The outbreaks of 2002/2003 SARS, 2012/2015 MERS and 2019/2020 Wuhan respiratory syndrome clearly indicate that genome evolution of an animal coronavirus (CoV) may enable it to acquire human transmission ability, and thereby cause serious threats to global public health. It is widely accepted that CoV human transmission is driven by the interactions of its spike protein (S-protein) with human receptor on host cell surface; so, quantitative evaluation of these interactions may be used to assess th...
34 CitationsSource
Cited By143
Newest
#1Xiaohan Wei (Southern Medical University)
#2Zhejun Zhao (Southern Medical University)
Last. Xiaomei Tan (Southern Medical University)H-Index: 8
view all 4 authors...
Abstract null null Ethnopharmacological relevance null Herbacetin is an active constituent of traditional Chinese medicines such as Ephedra sinica Stapf (MaHuang) and Sedum roseum (L.). Scop. (Hong JingTian). MaHuang was used to treat cough, asthma, fever, and edema for more than 5000 years, while Hong JingTian was used to treat depression, fatigue, cancers, and cardiovascular disease. Recent studies indicate that herbacetin and its glycosides play a critical role in the pharmacological activiti...
Source
#1Qinhai Ma (Guangzhou Medical University)H-Index: 4
#2Yuqi Xie (Guangzhou Medical University)H-Index: 3
Last. Zifeng Yang (Guangzhou Medical University)H-Index: 20
view all 10 authors...
BACKGROUND: Although the rapid emergence of coronavirus disease 2019 (COVID-19) poses a considerable threat to global public health, no specific treatment is available for COVID-19. ReDuNing injection (RDN) is a traditional Chinese medicine known to exert antibacterial, antiviral, antipyretic, and anti-inflammatory effects. In addition, RDN has been recommended in the diagnosis and treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-associated pneumonia by the National Heal...
Source
#1Xiaozheng Wu (Guida: Guizhou University)
#2Wen LiH-Index: 2
Last. Yunzhi ChenH-Index: 2
view all 7 authors...
Background null Coronavirus disease 2019 (COVID-19) in many countries is still very serious. At present, there is no specific and effective drug for this disease. Traditional Chinese medicine (TCM) has played a great role in fighting against COVID-19. However, their effectiveness and safety are still obscure and deserve further investigation. The aim of the study was to evaluate the efficacy and safety of TCM assisted in conventional treatment in the treatment of mild and common COVID-19. null M...
Source
#1Ming Lyu (Tianjin University of Traditional Chinese Medicine)H-Index: 1
#2Guanwei Fan (Tianjin University of Traditional Chinese Medicine)H-Index: 23
Last. Han Zhang (Tianjin University of Traditional Chinese Medicine)H-Index: 6
view all 15 authors...
COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread across the globe, posing an enormous threat to public health and safety. Traditional Chinese medicine (TCM), in combination with Western medicine (WM), has made important and lasting contributions in the battle against COVID-19. In this review, updated clinical effects and potential mechanisms of TCM, presented in newly recognized three distinct phases of the disease, are summarized and discussed....
Source
#1Yichang Yang (ZJU: Zhejiang University)
#2Jinzhou Tian (Beijing University of Chinese Medicine)
Source
Background: The outbreak of coronavirus disease 2019 (COVID-19) has rapidly spread to become a global emergency since December 2019. Chinese herbal medicine (CHM) plays an important role in the treatment of COVID-19. Chinese herbal medicine honeysuckle is an extremely used traditional edible and medicinal herb. Many trials suggest that honeysuckle have obtained good curative effect for COVID-19; however, no systematic evaluation on the clinical efficacy of honeysuckle in the treatment of COVID-1...
Source
#1Lianxiang LuoH-Index: 2
#2Qin QiuH-Index: 1
Last. Hui LuoH-Index: 2
view all 9 authors...
Since December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been found to be the culprit in the coronavirus disease (COVID-19), causing a global pandemic. Despite the existence of many vaccine programs, the number of confirmed cases and fatalities due to COVID-19 is still increasing. Furthermore, a number of variants have been reported. Because of the absence of approved anti-coronavirus drugs, the treatment and management of COVID-19 has become a global challenge. Unde...
Source
#1Aleksander Gajewski (UMK: Nicolaus Copernicus University in Toruń)
#2Anna Kośmider (UMK: Nicolaus Copernicus University in Toruń)
Last. Michał Wiciński (UMK: Nicolaus Copernicus University in Toruń)H-Index: 13
view all 5 authors...
Abstract null null The COVID-19 epidemy is the greatest pandemic that human kind experienced for decades, with high morbidity and mortality. Despite recent development of vaccines there is still many severe cases of COVID-19. Unfortunately there is still no standardised therapies and treatment of severe cases is very challenging. The aim of this study is to indicate if herbs administered alone or as a complementary therapy could be used as prophylaxis or treatment of SARS-CoV-2 infection. null O...
Source
#1Jun Li (TJU: Tianjin University)H-Index: 15
#2Ziao Zhou (Huda: Hubei University)H-Index: 3
Last. Zhaoyang Li (TJU: Tianjin University)H-Index: 46
view all 14 authors...
Summary null Clinically, lethal viral-bacterial pneumonia is a severe threat to human health worldwide. Here, for the first time, we propose a "material-herbology" strategy, in which herbal medicines are utilized as materials or refreshed by using materialogy methods to enhance their therapeutic effect. Specifically, in this work, natural tea nanodots (TNDs, with an average size of ~3 nm) are made from several kinds of catechins extracted from Chinese black tea (Black TNDs). The antibacterial me...
1 CitationsSource
#1Kai Huang (UCLA: University of California, Los Angeles)H-Index: 3
#2Pan Zhang (China-Japan Friendship Hospital)H-Index: 1
Last. Hua Cai (UCLA: University of California, Los Angeles)H-Index: 49
view all 7 authors...
COVID-19 has remained an uncontained, worldwide pandemic. While battling for the disease in China, six Traditional Chinese Medicine (TCM) recipes have been shown to be remarkably effective for treating patients with COVID-19. The present review discusses principles of TCM in curing infectious disease, and clinical evidence and mechanisms of the 6 most effective TCM recipes used in treating COVID-19 in 92% of all of the confirmed cases in China. Applications of TCM and specific recipes in the tre...
7 CitationsSource